Skip to main content
. 2023 Jul 22;7(6):856–862. doi: 10.1002/ags3.12717

FIGURE 2.

FIGURE 2

The answers to question 2 at the consensus meeting: what kind of gastric cancer patients do you offer neoadjuvant chemotherapy to (multiple answers are allowed)? CY1, positive lavage cytology; LN, lymph node.